DiaSys Diagnostic Systems is a leading specialist in developing and manufacturing odiagnostic system solutions of highest quality, trusted by customers in more than 140 countries for over 30 years. DiaSys' product portfolio comprises more than 90 clinical chemistry and immunoturbidimetric reagents for routine and special diagnostics including dedicated calibrators and controls. The DiaSys instrumentation product range covers automated clinical chemistry analyzers, semi-automated analyzers and instruments for near-patient testing.
By the end of 2023, the Dutch subsidiary of Shenzhen based Mindray Bio-Medical Electronics Co., Ltd. announced complete acquisition of 75% stake in DiaSys Diagnostic Systems GmbH, now recognized as a majority-owned Mindray subsidiary.
This strategic alignment will substantially strenghten the joint global completitive edge in global in-vitro diagnostics.
News & Updates
On December 1, Shenzhen Mindray Bio-Medical Electronics Co., Ltd announced complete acquisition of 75% stake in Germany based DiaSys Diagnostics Systems GmbH. DiaSys is now recognized as a majority-owned Mindray subsidiary.